| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 31,683 | 35,142 | 27,246 | 28,143 | | Cost of Revenue | 24,373 | 26,133 | 21,848 | 21,783 | | | Gross Profit | 7,310 | 9,009 | 5,398 | 6,360 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,722 | 6,398 | 5,908 | 7,909 | | Non Recurring |
-
| 113 | 112 | 30,729 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 588 | 2,498 | (622) | (32,279) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 88 | 79 | 91 | 13 | | Earnings Before Interest And Taxes | 872 | 2,676 | (502) | (32,279) | | Interest Expense | 531 | 571 | 566 | 541 | | Income Before Tax | 341 | 2,105 | (1,068) | (32,820) | | Income Tax Expense | 247 | 366 | 7 | (2,719) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 418 | 1,739 | (1,075) | (30,101) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 94 | 1,739 | (1,075) | (30,101) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $94 | $1,739 | ($1,075) | ($30,101) |
|
0.02% Nasdaq 
Income Statement
